The differential effects of aspirin on platelets, leucocytes and vascular endothelium in an in vivo model of thrombus formation

Clinical and Laboratory Haematology

Volumn 21, Issue 1, 1999, Pages 33-40

  Nagamatsu, Y ^a   Tsujioka, Y ^a   Hashimoto, M ^a   Giddings, J C ^b   Yamamoto, J ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Aspirin; Leucocytes; Platelets; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; VINBLASTINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL MODEL; INTRAVENOUS DRUG ADMINISTRATION; LASER; LEUKOCYTE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; ASPIRIN; BLOOD COAGULATION; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; LASERS; LEUKOCYTES; MALE; RATS; THROMBOSIS;

EID: 0033038134     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1999.00189.x     Document Type: Article

References (54)

1. Adams H.P. & Bendixen B.H. (1993) Low-versus high-Jose aspirin in prevention of ischemic stroke. Clinical Neuropharmacology 16, 485-500.
2. Altieri D.C. (1993) Coagulation assembly on leucocytes in transmembrane signalling and cell adhesion. Blood 81, 569-579.
3. Altman R. & Scazziota A. (1996) Why aspirin cannot prevent arterial thrombosis. Circulation 94, 3002-3003.
4. Altman R., Scazziotta A. & Rouvier J. (1998) Daily 50 mg or 500 mg aspirin does not affect the cooperation of arachidonic acid and ADP on platelet aggregation. Circulation 97, 118-119.
5. Angelini G.D. & Breckenridge I.J. (1985) Is there a rationale for treatment with aspirin before coronary surgery? Lancet 2, 843.
6. Antiplalelet Trialisls' Collaboration (1994) Collaborative overview of randomised trials of antiplatelet therapy, I: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. British Medical Journal 308, 81-106.
7. Buchanan M.R., Dejana E., Cazenave J.P., Richardson M., Mustard J.F. & Hirsh J. (1980) Differences in inhibition of PGI2 production by aspirin in rabbit artery and vein segments. Thrombosis Research 20, 447-460.
8. Cattaneo M., Pareti F.I., Zighetti M.L., Lecchi A., Lombardi R. & Mannucci P.M. (1995) Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time. Journal of Laboratory and Clinical Medicine 125, 540-547.
9. Claria J. & Serhan C.N. (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proceedings of the National Academy of Sciences of USA 92, 9475-9479.
10. Dinerman J.L. & Mehta J.L. (1990) Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights in to potential mechanisms and their clinical relevance. American College of Cardiology 16, 207-222.
11. FitzGerald G.A., Oats J.A., Hawiger J et al. (1983) Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. Journal of Clinical Investigation 71, 676-688.
12. Funk C.D., Funk L.B., Kennedy M., Pong A. & Fitzgerald G.A. (1991) Human platelet/erythroleukaemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB Journal 5, 2304-2312.
13. Furie B. & Furie B.C. (1997) Leukocyte crosstalk at the vessel wall. Thrombosis and Haemostasia 78, 306-309.
14. Gavaghan T.P., Gebski B. & Baron D.W. (1991) Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. Circulation 83, 1526-1533.
15. Gorog D. & Kovacs I.B. (1995) Thrombotic status analyser. Measurement of platelet-rich thrombus formation and lysis in native blood. Thrombosis and Haemostasia 73, 514-520.
16. Hanley S.P., Bevan J., Cockbill S.R. & Heptinstall S. (1981) Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet 1, 969-971.
17. Hernandez R., Alemany M., Bozzo J., Buchanan M.R., Ordinas A. & Bastida E. (1993) Platelet adhesivity to subendothelium is influenced by polymorphonuclear leukocytes: studies with aspirin and salicylate. Haemostasis 23, 1-7.
18. Ikarugi H., Taka T., Nakajima S et al. (1997) Detection of a prothrombotic state after acute aerobic exercise. Thrombosis Research 85, 351-356.
19. Imbault P., Doutremepuich F., Aguejouf O. & Doutremepuich C. (1996) Antithrombotic effects of aspirin and LMWH in a laser-induced model of arterial and venous thrombosis. Thrombosis Research 82, 469-478.
20. Jaffe E.A. & Weksler B.B. (1979) Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. journal of Clinical Investigation 63, 532-535.
21. Kawano M., Watanabe S., Sasaki Y., Giddings J.C. & Yamamoto J. (1997) Adjuvant effect of argatroban on staphylokinase induced thromholysis of platelet rich thrombi in rat mesenteric venules in vivo. Thrombosis Research 86, 115-126.
22. Kovacs I.B., Tigy-Sebes A., Tromtitas K. & Gorog P. (1975) Evans blue: an ideal energy absorbing material to produce intravascular microinjury by He-Ne gas laser. Microvascular Research 10, 107-124.
23. Kupper A.J.F., Verheugt F.W.A., Peels C.H., Galema T.W., Hollander W. & Roos J.P. (1989) Effect of low dose acetylsalicylic acid on the frequency and hematologic activity of left ventricular thrombus in anterior wall acute myocardial infarction. American journal of Cardiology 63, 917-920.
24. Leo R., Pratico D., Iuliano L., Pulcinelli F.M. et al. (1997) Platelet activation by Superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then re oxygenated. Circulation 95, 885-891.
25. Lopez-Farne A., Caramelo C., Esteban A. et al. (1995) Effects of aspirin on platelet-neutrophil interactions. Role of nitric oxide and endothelin-1. Circulation 91, 2080-2088.
26. Maalej N. & Folts J.D. (1996) Increased shear stress overcomes the antithromhotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries. Circulation 93, 1201-1205.
27. Marcus A.J. ( 1990) Thrombosis and inflammation as multicellular processes: pathophysiological significance of transcellular metabolism. Blood 76, 1903-1907.
28. Masotti G., Galanti G., Poggesi L., Abbate R. & Neri-Serneri G.G. (1979) Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancit 2, 1213-1216.
29. Mickelson J.K., Hoff P.T., Homeister J.W., Fantone J.C. & Lucchesi B.R. (1993) High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury. American College of Cardiology 21, 502-510.
30. Murata T., Ushikubi F., Matsuoka T. et al. (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388, 678-682.
31. Nicolini F.A., Wilson A.C., Mehta P. & Mehta J.L. (1990) Comparative platelet inhibitory effects of human neutrophils and lymphocytes. Journal of Laboratory and Clinical Medicine 116, 147-152.
32. Patrignani P., Filabozzi P. & Patrono C. (1982) Selective, cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. Journal of Clinical Investigation 69, 1366-1372.
33. Patrono C. & Roth G.J. (1996) Aspirin in ischaemic cerebrovascular disease. How strong is the case for a different dosing regimen? Stroke 27, 756-760.
34. Patterson C.E., Jin N., Packer C.S. & Rhoades R.A. (1992) Activated neutrophils alter contractile properties of the human pulmonary artery. American Journal of Respiratory Cellular and Molecular Biology 6, 260-269.
35. Povlishock J.T. & Rosenblum W.I. (1987) Injury of brain microvessels with a helium-neon laser and Evans blue can elicit local platelet aggregation without endothelial denudation. Archive Pathology and Laboratory Medicine 111, 415-421.
36. Preston F.E., Whipps S., Jackson C.A., French A.J., Wild P.J. & Stoddard C.J. (1981) Inhibition of prostacyclin and platelet thromboxane A2 after prostacyclin and platelet thromboxane A2 after low dose aspirin. New England Journal of Medicine 304, 76-79.
37. Ratnatunga C.P., Edmondson S.F. & Kovacs I.B. (1992) High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. Circulation 85, 1077-1082.
38. Roth G.J. & Calverley D.C. (1994) Aspirin, platelets and thrombosis. Theory and Practice. Blood 83, 885-898.
39. Roth G.J., Stanford N. & Majerus P.W. (1975) Acetylation of prostaglandin synthase by aspirin. Proceedings of the National Academy of Sciences of the USA 72, 3073-3076.
40. Salvemini D., de Nucci G., Gryglewski R.J. & Vane J.R. (1989) Human neutrophils and mononudear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proceedings of the National Academy of Sciences of the USA 86, 6328-6332.
41. Santos M.T., Valles J., Aznar J., Marcus A.J., Broekman M.J. & Safier L.B. (1997) Prothrombolic effects of erythrocytes on platelet reactivity: reduction by aspirin. Circulation 95, 63-68.
42. Schafer A.I. (1996) Antiplatelet therapy. American Journal of Medicine 101, 199-209.
43. Schattner M.A., Finiasz M.R., Notrica J.A. & Lazzari M.A. (1994) Platelet aggregation inhibition by mononuclear leukocytes. Thrombosis Research 73, 205-214.
44. Takiguchi Y., Hirata Y., Wada K. & Nakashima M. (1992) Arterial thrombosis model with photochemical reaction in guinea pig and its property. Thrombosis Research 67, 435-445.
45. Valles J., Santos T., Aznar J. et al. (1991) Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increasing thromboxane production, adenosine diphosphate release, and recruitment. Blood 78, 154-162.
46. Valles J., Santos M.T., Marcus A.J. et al. (1993) Down regulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesion proteins. Journal of Clinical Investigation 92, 1357-1365.
47. Villa S. & de Gaetano G. (1977) Prostacyclin-like activity in rat vascular tissues. Fast, long-lasting inhibition by treatment with lysine acetylsalicylate. Prostaglandins 14, 1117-1124.
48. Villa S., Livio M. & de Gaetano G. (1979) The inhibitory effect of aspirin on platelet and vascular prostaglandins in rats cannot be completely associated. British Journal of Haematology 42, 425-431.
49. Vogel G.M.T., van Amsterdam R.G.M., Zandbeg P. et al (1997) Two new closely related rat models with relevance to arterial thrombosis: efficacies of different antithrombotic drugs. Thrombosis and Haemostasis 77, 183-189.
50. Ware J.A. & Heistad D.D. (1993) Platelet-endothelium interactions. New England journal of Medicine 32, 628-635.
51. Weber C., Erl W., Pietsch A. & Weber P.C. (1995) Aspirin inhibits nuclear factor-kappa-B mobilization and monocyte adhesion in stimulated human endothelial cells. Circulation 91, 1914-1917.
52. Yamamoto J., Ishii I., Okada Y. et al. (1993) Effect of leucocyte products on platelet thrombus formation, coagulation and spontaneous thrombolysis, as measured from native human blood, in vitro. Thrombosis Research 71, 281-287.
53. Yamamoto J., Oyama T., Ishii I. et al. (1997) The differential involvement of von Willebrand factor, fibrinogen and Fibronectin in acute experimental thrombosis in rat cerebral and mesenteric microvessels. Japanese Journal of Physiology 47, 431-441.
54. Zalla A., Prodoscimi M., Bertele M., Bazzoni G. & del Maschio A. (1990) Inhibition of platelet function by polymorphonuclear leukocytes. Journal of Laboratory and Clinical Medicine 116, 651-660.